UK opens pediatric research program for children’s COVID-19 vaccine

In a media event today, it was announced UK has been selected as a site for KidCOVE, a national research study to ensure a safe and effective vaccine that protects children ages 6 months through 11 years from getting sick with COVID-19. Using the Moderna vaccine currently authorized for adults, this pediatric research study will… Read More